Harbor Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,500
Closed -$1.05M 164
2019
Q4
$1.05M Hold
5,500
0.28% 43
2019
Q3
$925K Hold
5,500
0.26% 48
2019
Q2
$913K Hold
5,500
0.27% 47
2019
Q1
$808K Hold
5,500
0.26% 55
2018
Q4
$730K Hold
5,500
0.28% 54
2018
Q3
$1.05M Hold
5,500
0.33% 46
2018
Q2
$927K Hold
5,500
0.3% 54
2018
Q1
$911K Hold
5,500
0.31% 54
2017
Q4
$900K Hold
5,500
0.31% 55
2017
Q3
$1.13M Hold
5,500
0.41% 33
2017
Q2
$1.34M Hold
5,500
0.53% 26
2017
Q1
$1.31M Buy
5,500
+1,000
+22% +$233K 0.56% 24
2016
Q4
$945K Buy
+4,500
New +$932K 0.45% 36

Other funds holding AGN

Harbor Advisors's AGN Position: Q1 2020 in Review

Harbor Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 5,500 shares — an estimated $1.05M sold.

Harbor Advisors first reported a position in AGN in Q4 2016 and held it in 13 quarters. The position peaked at $1.34M in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Harbor Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Harbor Advisors sold 5,500 Allergan plc shares in Q1 2020, an estimated $1.05M.
  • Harbor Advisors first reported a position in Allergan plc in Q4 2016 and held it in 13 quarters.
  • Harbor Advisors's Allergan plc position peaked at $1.34M in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Harbor Advisors's 13F filing for Q1 2020, filed 21 May 2020.